tiprankstipranks
Nanobiotix Reports Progress and Solid Financials
Company Announcements

Nanobiotix Reports Progress and Solid Financials

Nanobiotix (NBTX) has released an update.

Pick the best stocks and maximize your portfolio:

Nanobiotix, a biotech firm, reported promising therapeutic results with its lead candidate, NBTXR3, which showed favorable safety and tumor response in cancer patients and is expected to reach several clinical milestones for various cancers in the next 12-18 months. Financially, the company announced a cash position of €66.3 million as of June 2024, sufficient to fund operations into the fourth quarter of 2025, alongside an increase in revenue to €9.3 million compared to the previous year.

For further insights into NBTX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskNanobiotix to Unveil Future of Nanotherapeutics
TipRanks Auto-Generated NewsdeskNanobiotix Announces Key Share Acquisition Transactions
TipRanks Auto-Generated NewsdeskNanobiotix Executive Acquires Significant Share Volume, Signaling Confidence in Future Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App